1. Home
  2. WINT vs XPON Comparison

WINT vs XPON Comparison

Compare WINT & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WINT
  • XPON
  • Stock Information
  • Founded
  • WINT 1992
  • XPON 2016
  • Country
  • WINT United States
  • XPON United States
  • Employees
  • WINT N/A
  • XPON N/A
  • Industry
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • XPON Electronic Components
  • Sector
  • WINT Health Care
  • XPON Technology
  • Exchange
  • WINT Nasdaq
  • XPON Nasdaq
  • Market Cap
  • WINT 2.0M
  • XPON 1.9M
  • IPO Year
  • WINT 1995
  • XPON 2022
  • Fundamental
  • Price
  • WINT $0.12
  • XPON $1.33
  • Analyst Decision
  • WINT Hold
  • XPON
  • Analyst Count
  • WINT 1
  • XPON 0
  • Target Price
  • WINT $7.00
  • XPON N/A
  • AVG Volume (30 Days)
  • WINT 7.3M
  • XPON 312.5K
  • Earning Date
  • WINT 11-27-2024
  • XPON 03-27-2025
  • Dividend Yield
  • WINT N/A
  • XPON N/A
  • EPS Growth
  • WINT N/A
  • XPON N/A
  • EPS
  • WINT N/A
  • XPON N/A
  • Revenue
  • WINT N/A
  • XPON $4,498,181.00
  • Revenue This Year
  • WINT N/A
  • XPON N/A
  • Revenue Next Year
  • WINT N/A
  • XPON $66.62
  • P/E Ratio
  • WINT N/A
  • XPON N/A
  • Revenue Growth
  • WINT N/A
  • XPON N/A
  • 52 Week Low
  • WINT $0.11
  • XPON $1.32
  • 52 Week High
  • WINT $14.75
  • XPON $473.00
  • Technical
  • Relative Strength Index (RSI)
  • WINT 15.60
  • XPON 30.42
  • Support Level
  • WINT $0.21
  • XPON $1.32
  • Resistance Level
  • WINT $0.33
  • XPON $1.75
  • Average True Range (ATR)
  • WINT 0.03
  • XPON 0.10
  • MACD
  • WINT 0.00
  • XPON -0.01
  • Stochastic Oscillator
  • WINT 2.15
  • XPON 2.18

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

About XPON Expion360 Inc.

Expion360 Inc is focused on the design, assembly, manufacturing and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles ("RV's") and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.

Share on Social Networks: